Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine exposure in tympanoplasty and sensorineural hearing loss
IRCT20200926048841N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of povidone-iodine in chronic otitis media (COM) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sensorineural hearing status. Started Sep 2020; status: completed.
02
Drugs
povidone-iodine
03
Conditions
chronic otitis media (COM)
Beyond the preview
Go deeper on IRCT20200926048841N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200926048841N1.